Assyro AI

FDA Orange Book · active-ingredient family

Albuterol

Albuterol is approved as 2 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PROVENTIL · NDA 017559

2

Brand (NDA)

4

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · aerosol, metered

ProductApplicantApplicationTEApproved
PROVENTILSCHERINGNDA 017559Approved Prior to Jan 1, 1982
VENTOLINGLAXOSMITHKLINENDA 018473Approved Prior to Jan 1, 1982

Generic (ANDA) products (4)

ProductApplicantApplicationTEApproved
ALBUTEROLGENPHARMANDA 073045Aug 19, 1997
ALBUTEROLARMSTRONG PHARMSANDA 072273Aug 14, 1996
ALBUTEROLPLIVAANDA 074072Aug 01, 1996
ALBUTEROLIVAX SUB TEVA PHARMSANDA 073272Dec 28, 1995

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Albuterol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.